Treatment for Geriatric Patients with Chronic Cough and Brown Sputum
Diagnosis and Classification
- Chronic bronchitis is defined as cough and sputum expectoration occurring on most days for at least 3 months of the year and for at least 2 consecutive years, with morning cough with brown sputum being particularly characteristic 3, 4, 5
- Brown sputum typically indicates chronic inflammation in the airways with mucus hypersecretion 3
First-Line Treatment
- The American College of Chest Physicians recommends ipratropium bromide as first-line therapy with Grade A evidence for geriatric patients with chronic cough producing brown sputum 1, 2
- Ipratropium bromide dosage is 36 μg (2 inhalations) four times daily, which decreases cough frequency and severity while reducing sputum volume 1
- Ipratropium bromide significantly improves cough symptoms compared to placebo in patients with chronic bronchitis 2
Alternative and Add-on Treatments
- Short-acting β-agonists can be added as second-line therapy, but have less consistent effects on cough compared to ipratropium bromide 2
- For patients with severe airflow obstruction or frequent exacerbations, consider adding an inhaled corticosteroid with a long-acting β-agonist 2
- Central acting antitussive agents like codeine or dextromethorphan can provide short-term symptomatic relief for severe paroxysms of cough, reducing cough counts by 40-60% in patients with chronic bronchitis 6, 2
Treatment Considerations for Geriatric Patients
- Anticholinergics like ipratropium have a favorable side effect profile in older adults compared to β-agonists 1
- Ensure proper inhaler technique, which is essential for medication efficacy, especially in geriatric patients 2
- Avoid theophylline due to narrow therapeutic index and potential for drug interactions, which are particularly problematic in older adults 2
Addressing Underlying Causes
- Evaluate for and address exposure to respiratory irritants (tobacco smoke, environmental pollutants) 7
- Smoking cessation is the most effective intervention if the patient is a smoker, with 90% of patients with chronic cough who stop smoking reporting resolution of cough 7
When to Consider Additional Evaluation
- If cough persists beyond 8 weeks despite appropriate therapy, consider additional evaluation 8
- If there is a change in the character of cough for prolonged periods, consider additional diagnoses including malignancy 7
- Consider evaluation for other common causes of chronic cough (UACS, asthma, GERD) if response to treatment is inadequate 8
Monitoring and Follow-up
- Assess improvement in cough frequency and severity after starting ipratropium bromide 1
- Monitor for changes in sputum color or volume that might indicate an acute exacerbation 3
- If symptoms worsen acutely with increased sputum volume or purulence, consider treatment for an acute exacerbation of chronic bronchitis 3, 7